• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS PREMIER¿; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS PREMIER¿; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493952838400
Medical Device Problem Codes Device Damaged by Another Device (2915); Device Dislodged or Dislocated (2923)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 05/02/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).
 
Event or Problem Description
It was reported that stent dislodgement occurred.The 60% stenosed target lesion was located in the mildly tortuous and mildly calcified tibioperoneal trunk.A 4.00x38mm promus premier¿ drug-eluting stent was advanced to treat the lesion.However, the stent was caught on a previously implanted non-bsc stent and was dislodged from the delivery system.The dislodged stent was then post dilated in the popliteal artery and the procedure was completed with a different device.No patient complications were reported and the patient's status was fine.
 
Additional Manufacturer Narrative
Device evaluated by mfr: promus premier us mr 4.00 x 38mm stent delivery system was returned for analysis.The stent was not returned for analysis as it was deployed in the patient during the procedure.The manufacturing data for this device was reviewed and no anomalies were highlighted with the crimp details.The maximum stent profile was within maximum crimped stent profile measurement.The balloon appeared to have been subjected to positive pressure and a vacuum pulled.A visual and tactile examination of the hypotube revealed multiple kinks.An examination of the shaft polymer extrusion revealed multiple kinks.The tip was visually examined and damage was noted.No other issues were identified during the product analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The investigation conclusion is caused by other device as another device/drug/subsequent procedure caused the complaint event.(b)(4).
 
Event or Problem Description
It was reported that stent dislodgement occurred.The 60% stenosed target lesion was located in the mildly tortuous and mildly calcified tibioperoneal trunk.A 4.00x38mm promus premier drug-eluting stent was advanced to treat the lesion.However, the stent was caught on a previously implanted non-bsc stent and was dislodged from the delivery system.The dislodged stent was then post dilated in the popliteal artery and the procedure was completed with a different device.No patient complications were reported and the patient's status was fine.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS PREMIER¿
Common Device Name
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
MDR Report Key7544497
Report Number2134265-2018-04554
Device Sequence Number1453050
Product Code NIQ
UDI-Device Identifier08714729845041
UDI-Public08714729845041
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
P110010
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 05/02/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/30/2019
Device Model NumberH7493952838400
Device Catalogue Number39528-3840
Device Lot Number0021722056
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/08/2018
Initial Date Received by Manufacturer 05/02/2018
Supplement Date Received by Manufacturer05/29/2018
Initial Report FDA Received Date05/25/2018
Supplement Report FDA Received Date06/18/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
-
-